In Arizona, Axolotl Biologix, a regenerative human cell and tissue medical technologies company, entered into an exclusive worldwide license agreement with Protein Genomics, Inc., an R&D company focused on biopolymers for applications in wound healing and tissue regeneration. The license agreement allows Axolotl Biologix to use Protein Genomics’ patents and manufacturing knowledge for a biomimetic skin substitute made from biomaterial called Elastropin. This will help grow and expand Axolotl Biologix’s burn, surgical and wound treatment products. Axolotl Biologix is also acquiring Protein Genomics’ research laboratory in Flagstaff as part of the agreement, and gave a heads up that they plan on filing three new patents in the very near future, so stay tuned.
Home Biomaterials Axolotl Biologix Acquires Protein Genomics’ Research Lab and Signs License Agreement
Latest article
Crude awakening: Kapoor’s renewable-material protest art installed on Shell gas platform
In the North Sea, protest art made by Anish Kapoor, using renewable materials such as used coffee grounds and beetroot powder, has been installed...
Tiny Vinyl to release tiny, biobased PVC records
In the US, a startup called Tiny Vinyl has created cute, mini, vinyl records out of bio-attributed polyvinyl chloride. The 4-inch mini singles play...
Fun with Fungi: Japanese designers create mycelium block-growing kit
In Japan, designers have created a biomaterial kit for growing toy blocks out mycelium. Dubbed MYMORI, the kit includes block molds and a mycelium...